PITT-HOPKINS SYNDROME
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
We suggest careful studies in parents of other patients with PTHS to determine the frequency of germline and somatic mosaicism for TCF4 mutations.
|
22335494 |
2013 |
PITT-HOPKINS SYNDROME
|
1.000 |
Biomarker
|
disease |
BEFREE |
Haploinsufficiency of the class I bHLH transcription factor TCF4 causes Pitt-Hopkins syndrome (PTHS), a severe neurodevelopmental disorder, while common variants in the <i>TCF4</i> gene have been identified as susceptibility factors for schizophrenia.
|
29588831 |
2018 |
PITT-HOPKINS SYNDROME
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
CGH-array allowed characterisation of a de novo 6.2 Mb 18q21.2q21.32 interstitial deletion involving TCF4, the recently identified gene responsible for Pitt-Hopkins syndrome (PHS).
|
18222743 |
2008 |
PITT-HOPKINS SYNDROME
|
1.000 |
Biomarker
|
disease |
BEFREE |
Haploinsufficiency of TCF4 causes Pitt-Hopkins syndrome (PTHS): a severe form of mental retardation with phenotypic similarities to Angelman, Mowat-Wilson and Rett syndromes.
|
24058414 |
2013 |
PITT-HOPKINS SYNDROME
|
1.000 |
Biomarker
|
disease |
BEFREE |
In order to provide a molecular biological context for the loss of function of TCF4 in PTHS, the review will also present a brief overview of the basic biochemistry of TCF4-mediated regulation of cellular and neuronal gene expression.
|
23640545 |
2013 |
PITT-HOPKINS SYNDROME
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
TCF4 mutations also cause Pitt-Hopkins Syndrome, an autosomal-dominant neurodevelopmental disorder associated with severe mental retardation.
|
20421335 |
2010 |
PITT-HOPKINS SYNDROME
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Mutations in TCF4 are a known cause of Pitt-Hopkins syndrome.
|
27270050 |
2016 |
PITT-HOPKINS SYNDROME
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
TCF4 mutational analysis was performed in 117 patients with PTHS-like features.
|
18728071 |
2008 |
PITT-HOPKINS SYNDROME
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
The deletion of the transcription factor 4 gene suggested a possible contribution of the deletion to the patient's facial abnormalities, as observed in Pitt-Hopkins syndrome.
|
19813260 |
2010 |
PITT-HOPKINS SYNDROME
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
However, a frameshift mutation in TCF4 was identified in a patient with a clinical diagnosis of "variant" RTT, in whom the clinical evolution later raised the possibility of Pitt-Hopkins syndrome.
|
22383159 |
2012 |
PITT-HOPKINS SYNDROME
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
As mutations in TCF4 cause Pitt-Hopkins syndrome (PTHS) characterized by severe intellectual disability, our data also potentially provide insights into the basis of neurological defects linked to TCF4 mutations.
|
31845732 |
2019 |
PITT-HOPKINS SYNDROME
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Haploinsufficiency of the TCF4 gene has been found to be associated with the Pitt-Hopkins syndrome (PTHS).
|
20184619 |
2010 |
PITT-HOPKINS SYNDROME
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
TCF4 deletions in Pitt-Hopkins Syndrome.
|
18781613 |
2008 |
PITT-HOPKINS SYNDROME
|
1.000 |
Biomarker
|
disease |
BEFREE |
Our data indicate effects of TCF4 perturbation on human cortical progenitor cell proliferation, a process that could contribute to cognitive deficits in individuals with Pitt-Hopkins syndrome and risk for schizophrenia.
|
27689884 |
2017 |
PITT-HOPKINS SYNDROME
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Our review of previously reported cases with TCF4 mutations and deletions showed that all patients with Pitt-Hopkins syndrome reported to date have severe psychomotor retardation, the onsets of seizures and hyperventilation episodes are limited to the first decade in most reported patients with Pitt-Hopkins syndrome, hyperventilation episodes are more common than seizures and are seen in the oldest patients, and individuals with missense TCF4 mutations are more likely to develop seizures.
|
19938247 |
2009 |
PITT-HOPKINS SYNDROME
|
1.000 |
Biomarker
|
disease |
BEFREE |
Transcriptional factor 4 (TCF4), encoding a basic helix-loop-helix transcriptional factor, has recently been demonstrated as a causative gene for Pitt-Hopkins syndrome, a neurodevelopmental disease.
|
18635522 |
2008 |
PITT-HOPKINS SYNDROME
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
In this study, we performed an in-depth analysis of the neurologic and ophthalmologic phenotype in a patient with Pitt-Hopkins syndrome (PTHS), a disorder characterized by severe mental and motor retardation, carrying a uniallelic TCF4 deletion, and studied a zebrafish model.
|
21544580 |
2011 |
PITT-HOPKINS SYNDROME
|
1.000 |
Biomarker
|
disease |
BEFREE |
Impairment of different protein domains causes variable clinical presentation within Pitt-Hopkins syndrome and suggests intragenic molecular syndromology of TCF4.
|
28807867 |
2017 |
PITT-HOPKINS SYNDROME
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Pitt-Hopkins syndrome (PTHS) is a rare, genetic disorder caused by a molecular variant of TCF4 which is involved in embryologic neuronal differentiation.
|
29318938 |
2018 |
PITT-HOPKINS SYNDROME
|
1.000 |
AlteredExpression
|
disease |
BEFREE |
These data demonstrate that PTHS-associated missense mutations can have multiple effects on the function of the protein, and suggest that TCF4 may modulate the expression of NRXN1 and CNTNAP2 thereby defining a regulatory network in PTHS.
|
22777675 |
2012 |
PITT-HOPKINS SYNDROME
|
1.000 |
PosttranslationalModification
|
disease |
BEFREE |
Mutational, functional, and expression studies of the TCF4 gene in Pitt-Hopkins syndrome.
|
19235238 |
2009 |
PITT-HOPKINS SYNDROME
|
1.000 |
Biomarker
|
disease |
BEFREE |
We conclude that different PTHS-associated mutations impair the functions of TCF4 by diverse mechanisms and to a varying extent, possibly contributing to the phenotypic variability of PTHS patients.
|
22460224 |
2012 |
PITT-HOPKINS SYNDROME
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Rare TCF4 coding variants are found in individuals with Pitt-Hopkins syndrome-an intellectual disability and autism spectrum disorder.
|
31081034 |
2019 |
PITT-HOPKINS SYNDROME
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Therefore, we reevaluated ten patients carrying a pathogenic or likely pathogenic variant in TCF4 (eight patients included in this study and two from our previous ID-HTS study) for PTHS criteria defined by Whalen and Marangi.
|
29695756 |
2018 |
PITT-HOPKINS SYNDROME
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
The findings in our family support the notion that the position of the mutation in TCF4 is relevant to the phenotype, with those mutations in the 5' region, cassette exons and regions not affecting the important functional domains being linked to NSID rather than PTHS.
|
27132474 |
2016 |